Table 1.
Clinical and metabolic features of the AT-Ctrl and AT-OB.
| Clinical or Metabolic Characterization | AT-Ctrl 1 | AT-Ctrl 2 | AT-OB 1 | AT-OB 2 | AT-OB 3 |
|---|---|---|---|---|---|
| Sex | male | male | male | male | female |
| Age | 9 | 9 | 13 | 10 | 14 |
| Weight (kg) | 35 | 44 | 68 | 60.5 | 76 |
| Height (cm) | 146 | 144 | 154 | 148 | 161 |
| Body mass index (BMI) (kg/m2) | 16.4 | 21.2 | 28.7 | 27.6 | 29.3 |
| Fasting blood glycemia (mg/dL) (nv < 100) | 78 | 71 | 79 | 82 | 77 |
| Tryglicerides (mg/dL) (nv ≥ 130 mg/dL if ≥ 10 years) | 60 | 65 | 84 | 59 | 145 |
| HDL-cholesterol (mg/dL) (nv < 40 in females; nv < 50 in males) | 60 | 55 | 33 | 48 | 40 |
| Triglycerides/HDL-cholesterol ratio (nv < 2.2) | 1 | 1.1 | 2.5 | 1.2 | 3.6 |
| Triglyceride–glucose index (nv < 7.88) | 7.7 | 7.7 | 8.14 | 7.7 | 8.6 |
Triglyceride–glucose index was calculated as ln(fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2), and it was assumed as a surrogate of insulin resistance. “nv” indicates the normal value for the different features.